This white paper maps where AI is genuinely transforming analytical workflows, where adoption remains in the pilot
phase, and what the barriers to broader deployment look like in practice. It addresses the full spectrum of analytical
science — from method development and spectral interpretation to stability data analysis, impurity profiling, and
real-time release testing. It also examines the significant communication gap between analytical technology
vendors and the scientific audiences they are trying to reach.

This white paper cuts through the noise. It maps where AI genuinely improves experimental efficiency, identifies
the structural barriers that limit broader adoption, and draws practical conclusions for R&D; organisations
navigating investment decisions. Crucially, it also addresses a challenge that receives far too little attention: how
companies in this space should communicate about these technologies — to partners, clients, and the market.

Laboratory automation in chemical R&D is approaching an inflection point. The technology is mature enough todeliver transformative value across a broad range of applications. The organisations that will lead the next decadeof chemical R&D productivity will be those that invest now — not just in hardware, but in the workflow redesign,data infrastructure, and scientific culture change that makes automation valuable.

Industry surveys and market analyses suggest that a majority of pharmaceutical companies have reconsidered at
least one CDMO partnership in recent years as outsourcing strategies evolve. At the same time, the number of
evaluation criteria applied in CDMO selection has expanded significantly compared to five years ago, reflecting
growing concerns around supply chain resilience, regulatory risk, and technological capability.

The petfood industry is no longer a niche category defined by commodity kibble and canned meat. It is a global consumer goods and life sciences sector, valued in excess of $130 billion, growing faster than most food categories, and increasingly defined by the same forces shaping premium human nutrition: personalisation, preventive health, ingredient transparency, and digital commerce.

This white paper addresses the full packaging value chain — from material converters and flexible packaging producers to integrated processing and packaging machinery providers — across the segments and geographies where change is most acute. It identifies where market dynamics, regulatory pressure, and buyer behaviour are shifting fastest, and what the implications are for companies competing across this landscape.

This paper covers the full landscape: the state of the industry, the EV race and who is winning it, Chinese competitive dominance, the transformative role of AI across the value chain, the environmental reality of both ICE and electric technologies, the extraordinary acoustic and quality-of-life transformation an all-EV urban environment would represent, the second life of the battery, the structural risk to the US industry, the challenges in emerging markets, and what it all means for the B2B ecosystem that serves automotive manufacturers and suppliers globally.

This paper does not diagnose doom. It diagnoses reality — and then points toward a credible way forward. The path requires political courage, industrial boldness, and a fundamental reform of how Europe thinks about competitiveness, regulation, and the relationship between environmental ambition and industrial survival. It also requires companies to communicate more boldly, adopt AI more decisively, and make their case to governments with the same clarity and evidence they apply to their technical processes.